🔎 Trials Near Me

Hjem › Type 2-diabetes › South Carolina

Type 2-diabetes kliniske forsøg i South Carolina

20 studier for Type 2-diabetes søger deltagere på steder i South Carolina.

Byer i South Carolina

Officiel studietekst (engelsk)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Monroe Biomedical Research - Charleston, North Charleston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Piedmont Research Partners, LLC, Fort Mill
  • Velocity Clinical Research-Gaffney-69046, Gaffney
  • Tribe Clinical Research LLC - Greenville, Greenville
  • og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • PanAmerican Clinical Research - Bluffton, Bluffton
  • Spartanburg Medical Research, Spartanburg
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Medical University of South Carolina, Charleston
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Accellacare - Mt Pleasant, Mt. Pleasant
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

Improving the Collaborative Health of Adult Dyads

  • University of South Carolina, Columbia
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05370014

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Bluffton
  • AURORA-2 Clinical Site, Clemson
  • AURORA-2 Clinical Site, Columbia
  • og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Monroe Biomedical Research Charleston, North Charleston
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Coastal Carolina Research Center, North Charleston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • Monroe Biomedical Research, LLC, North Charleston
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Myrtle Beach
  • Research Site, North Charleston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Anderson, Anderson
  • Accellacare Charleston, Mt. Pleasant
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

  • Research Site, Gaffney
  • Research Site, Greenville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Piedmont Research Partners, LLC, Fort Mill
  • Accellacare US Inc._SC, Mt. Pleasant
  • Trial Management Associates, Myrtle Beach
RekruttererFase 3
Alder 45 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07797335

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

  • Research Site, Gaffney
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07606066

Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

  • Clemson Health Clinic at Orangeburg, Orangeburg
  • Clemson Health Clinic at Walhalla, Walhalla
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomneNævner betaling til deltagere
Alder 40 til 70 · Alle køn · Opdateret 18. aug. 2026 · NCT07731399

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Prisma Health Pediatric Endocrinology, Columbia
  • Prisma Health Midlands, Greenville
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

  • Research Site, Myrtle Beach
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT07664553

CGM for Management of Type 2 Diabetes in Pregnancy

  • Prisma Health Greenville Memorial Hospital, Greenville
Rekrutterer
Alder 18 til 50 · Kvinder · Opdateret 29. jun. 2026 · NCT06628453

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.